By Kyle J. Norton
Nonalcoholic steatohepatitis (NASH), is a type of inflammatory non-alcoholic fatty liver disease caused by a buildup of fat in the liver.
Nonalcoholic steatohepatitis (NASH), is a type of inflammatory non-alcoholic fatty liver disease caused by a buildup of fat in the liver.
Most common symptoms are abdominal swelling, enlarged blood vessels just beneath the skin's surface, enlarged spleen, red palms, and jaundice.
If you have experienced some of the aforementioned symptoms that do not recede in a short period of time, you may have some forms of liver disease. Please check with your doctor to rule out the possibility.
Out of many prevalent factors associated with increased risk of non-alcoholic steatohepatitis, some researchers suggested the rise of the condition in the US population may be correlated to the promotion of the Western diet over the past few decades.
And, "Our results suggest that the quality and combination of carbohydrates and fat intake may be more relevant than their isolated amount; an increased fat intake with an excessive amount of n-6 fatty acids can be implicated in promoting necro-inflammation, and provides further grounds for individualized dietary therapy".
Tomato is red, edible fruit, genus Solanum, belongings to family Solanaceae, native to South America. Because of its health benefits, the tomato is grown worldwide for the commercial purpose
and often in the greenhouse.
In the urgency to discover healthy foods for the treatment of liver disease, researchers examined the effect of lycopene, a non-provitamin A carotenoid and the pigment principally responsible for the characteristic deep-red color of ripe tomato and tomato products on subjects with non-alcoholic steatohepatitis.
and often in the greenhouse.
In the urgency to discover healthy foods for the treatment of liver disease, researchers examined the effect of lycopene, a non-provitamin A carotenoid and the pigment principally responsible for the characteristic deep-red color of ripe tomato and tomato products on subjects with non-alcoholic steatohepatitis.
According to the review of the epidemiological study, tomato extract supplementation showed a significant protective effect against HFD-induced hepatic inflammation compared supplementation of lycopene.
In patients with NASH, increased levels of plasma lycopene may have a strong impact on the progression of NASH as patients have been shown to have significantly reduced plasma lycopene.
In vivo, dietary lycopene inhibits liver carcinogen-induced preneoplastic lesions in the rat liver that was effective in reducing NASH-promotion in rats.
The efficacy of lycopene in the inhibition of NASH and another chronic disease may be associated with the body in lycopene metabolism involved in both the chemical and enzymatic modifications.
Futhermore, in vivo synthesis of ACR from lycopene showed to attenuate hepatic steatosis, by decreasing the macrophage conditioned medium induced and TNFα-mediated induction of pro-inflammatory cytokine and chemokines.
Taken altogether, tomato processed a high amount of lycopene may be considered a dietary supplements for the prevention and treatment of NASH, pending to large sample size and multicenter human study.
Natural Medicine for Fatty Liver And Obesity Reversal - The Revolutionary Findings To Achieve Optimal Health And Lose Weight
How To Get Rid Of Eye Floaters
Contrary To Professionals Prediction, Floaters Can Be Cured Naturally
Ovarian Cysts And PCOS Elimination
Holistic System In Existence That Will Show You How To
Permanently Eliminate All Types of Ovarian Cysts Within 2 Months
Back to Kyle J. Norton Homepage http://kylejnorton.blogspot.ca
Author Biography
Kyle J. Norton (Scholar, Master of Nutrition, All right reserved)
Health article writer and researcher; Over 10.000 articles and research papers have been written and published online, including worldwide health, ezine articles, article base, health blogs, self-growth, best before it's news, the karate GB daily, etc.,.
Named TOP 50 MEDICAL ESSAYS FOR ARTISTS & AUTHORS TO READ by Disilgold.com Named 50 of the best health Tweeters Canada - Huffington Post
Nominated for shorty award over last 4 years
Some articles have been used as references in medical research, such as international journal Pharma and Bioscience, ISSN 0975-6299.
Sources
(1) Non-alcoholic steatohepatitis and hepatocellular carcinoma: implications for lycopene intervention by Ip BC1, Wang XD. (PubMed)
(2) How different is the dietary pattern in non-alcoholic steatohepatitis patients? by H. Cortez-Pintoa, L. Jesusa, H. Barrosc, C. Lopesc, M.C. Mourab, and M.E. Camiloa. (Clinical Nutrition)
Intake of lycopene in the form of supplement should be taken with extreme care to prevent overdose acute liver toxicity.
Natural Medicine for Fatty Liver And Obesity Reversal - The Revolutionary Findings To Achieve Optimal Health And Lose Weight
How To Get Rid Of Eye Floaters
Contrary To Professionals Prediction, Floaters Can Be Cured Naturally
Ovarian Cysts And PCOS Elimination
Holistic System In Existence That Will Show You How To
Permanently Eliminate All Types of Ovarian Cysts Within 2 Months
Back to Kyle J. Norton Homepage http://kylejnorton.blogspot.ca
Author Biography
Kyle J. Norton (Scholar, Master of Nutrition, All right reserved)
Health article writer and researcher; Over 10.000 articles and research papers have been written and published online, including worldwide health, ezine articles, article base, health blogs, self-growth, best before it's news, the karate GB daily, etc.,.
Named TOP 50 MEDICAL ESSAYS FOR ARTISTS & AUTHORS TO READ by Disilgold.com Named 50 of the best health Tweeters Canada - Huffington Post
Nominated for shorty award over last 4 years
Some articles have been used as references in medical research, such as international journal Pharma and Bioscience, ISSN 0975-6299.
(1) Non-alcoholic steatohepatitis and hepatocellular carcinoma: implications for lycopene intervention by Ip BC1, Wang XD. (PubMed)
(2) How different is the dietary pattern in non-alcoholic steatohepatitis patients? by H. Cortez-Pintoa, L. Jesusa, H. Barrosc, C. Lopesc, M.C. Mourab, and M.E. Camiloa. (Clinical Nutrition)